Snowfire AI, a trailblazer in the rapidly evolving $4.1 trillion AI economy, today announced a major funding milestone by raising $2,300,000. This substantial investment highlights the increasing market confidence in Snowfire’s innovative Adaptive AI Decision Intelligence platform, which is revolutionizing how critical business data is harnessed for real-time decision making. Designed with the modern C-Suite in mind, Snowfire’s technology delivers deep, actionable insights to boardroom executives, effectively enabling them to navigate the complexities of today’s dynamic business landscape with the precision of SAP and the advanced analytics of firms like Palantir. The company aims to leverage this new funding to further refine its cutting-edge platform, growing its suite of AI-driven decision support tools and expanding its reach within global markets. By investing in strategic R&D, market expansion, and enhanced customer engagement, Snowfire AI is poised to accelerate its mission of transforming conventional decision-making processes. This investment will also help bring advanced AI capabilities to more businesses, empowering executives with data-driven insights that catalyze operational efficiencies, uncover new opportunities, and drive long-term strategic growth. As the AI revolution gathers pace, Snowfire AI’s innovative solutions position companies to stay ahead of technological trends and competitive pressures. For those interested in experiencing this breakthrough, Snowfire AI invites businesses to get started for free today at www.snowfire.ai, or to call 844-SNO-FIRE for additional information. This funding round marks an exciting new chapter for Snowfire AI, as it continues to lead the charge in redefining boardroom intelligence and driving the future of smart, decisive business leadership.

Snowfire AI Raises $2.3M Pre-Seed to Transform Boardroom Decision-Making in the $4.1T AI Economy
Get the full Snowfire AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Alitheon
Alitheon provides the last solution you will need for identification, authentication, and traceability of parts and products with our fail-proof, simple-to-use FeaturePrint system. FeaturePrint is an advanced machine-vision technology that provides for items, what fingerprints are for people – a unique and persistent identifier for the one in millions. FeaturePrint serializes items. As such, it enables track & trace, eliminates counterfeits and gray markets, and reduces human error ....all with just a photo using a standard camera. No bar codes, No QR codes, No stickers, No tags, No 'invisible' dust, No markers, No holograms, No special cameras, No special lighting, No Nonsense!
$8.0M Series a
today

The Ryl Company™
The Ryl Company™ is The Modern Tea Company — where nostalgic taste, clean ingredients, and functional benefits come together. Our flagship brand, Ryl Tea, reimagines the classic tea experience with zero sugar, 5 calories or less, nothing artificial, and antioxidant-powered functionality. We believe better-for-you should taste like the flavors you grew up loving. That’s why we exist: to help people Rethink Your Liquids (RYL). Available nationwide.
$20.0M Series c
today

Tavo Biotherapeutics
Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology. TAV-001 engages two novel targets that represent fundamental mechanisms underlying the pathology of glaucoma-related neurodegeneration. In pre-clinical studies, TAV-001 has shown signals of neuroprotection as well as substantial reduction in intraocular pressure, suggesting that it could represent the first disease-modifying pharmaceutical therapy for these patients. TAV-001 is expected to enter a Phase 1 clinical trial in glaucoma patients in 2025. TAV-002 represents a potential first-in-class treatment for retinal disease, including diabetic retinopathy, diabetic macular edema, and both wet and dry age-related macular degeneration. Tavo has initiated IND-enabling activities for this program.
$17.0M Series a
today

Adaptive Innovations Corp
Adaptive Innovations is an engineering firm and system integrator specializing in the design, fabrication, integration, and installation of custom equipment, automation & robotic solutions, tooling, fixtures, and gages. Comprised of a diverse group of professional engineers with backgrounds in design, controls, manufacturing, and electrical engineering disciplines, our outstanding team can help position your company to compete in today’s global economy. Combining industry best designs with exceptional process knowledge, fed by cross-industry exposure, Adaptive sets itself apart from its competition through every step of a project. We have a history of consistently delivering cost effective solutions, an excellent on-time delivery record, and unparalleled customer service, making Adaptive the engineering partner you can count on. Adaptive is considered the market leader in the design and fabrication of environmental test fixtures for testing such as HALT/HASS, ESS, and ED vibration or combined environments. We have experience with a wide array of automated solutions, including, assembly, pick-n-place, adhesive dispense, soldering, sorting, inspection etc. We're a Fanuc approved integrator, and have also integrated robots from ABB, Epson, Denso, and Adept. Our controls engineers are familiar with Beckhoff, Allen Bradley, Fanuc, Siemens, Mitsubishi, and National Instruments, contrllers and have a wide range of experience with robotic applications.
$50.0M Series a
today

Mia Health
Mia Health provides accurate risk assessments of large groups or populations which is crucial for the efficiency and resource optimization of health systems. With our customizable rapid screening and risk stratification platform you can now scale health systems significantly for more efficient and cost-effective population health management. Mia Health enables anyone to rapidly screen and stratify patient risk profiles using data collected through a smartphone in just 60 seconds. By measuring key vitals and providing critical insights to inform clinical or systemic decision-making, Mia Health simultaneously enables patient recommendations once a clinical decision has been made. Our proprietary cognitive AI encodes the expertise of dozens of world leading physicians making the Mia Health platform the most informed health stratification tool in the world and the only one of its kind. This eagerly anticipated and desperately needed technology is drastically closing the gap on delivering accessible, equitable care to all those who need it regardless of geographic location, economic status, race or gender. Learn More: https://www.miahealth.io
$920.0K Seed
today
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Everyday^ France | Pre-seed | $2.9M | today |
| 2 | ![]() Grupo NP Company | Pre-seed | $7.0M | today |
| 3 | ![]() Veeper United States | Pre-seed | $1.7M | today |
| 4 | ![]() Vestbee Poland | Pre-seed | $1.9M | 1d ago |
| 5 | ![]() Tiva Technologies United States | Pre-seed | $610.0K | 1d ago |




